The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial

Background: Referral to weight loss programmes is the only effective treatment for non-alcoholic fatty liver disease (NAFLD). Clinicians should advise weight loss and screen for liver fibrosis using the Enhanced Liver Fibrosis (ELF) score. Aim: To examine if the ELF score changes with weight loss. D...

Full description

Bibliographic Details
Main Authors: Dimitrios A. Koutoukidis, Susan A. Jebb, Paul Aveyard, Nerys M. Astbury
Format: Article
Language:English
Published: Karger Publishers 2020-03-01
Series:Obesity Facts
Subjects:
Online Access:https://www.karger.com/Article/FullText/505667